Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

Objective Treatment compliance among psychiatric patients is related to disease outcomes. How to assess patient compliance remains a concern. Here, we established a predictive model for medication ...

The USA is again at the top of the table, with $12,550 per capita spent on health. It is followed by Switzerland, with $8050, and Norway, with $7771. The OECD average is 4500 dollars, which is at ...